BICX
Price
$0.36
Change
+$0.02 (+5.88%)
Updated
Jun 27 closing price
Capitalization
18.29M
42 days until earnings call
EXETF
Price
$10.24
Change
+$0.05 (+0.49%)
Updated
Jul 3 closing price
Capitalization
459.44M
37 days until earnings call
Interact to see
Advertisement

BICX vs EXETF

Header iconBICX vs EXETF Comparison
Open Charts BICX vs EXETFBanner chart's image
BioCorRx
Price$0.36
Change+$0.02 (+5.88%)
Volume$561
Capitalization18.29M
Extendicare
Price$10.24
Change+$0.05 (+0.49%)
Volume$1.41K
Capitalization459.44M
BICX vs EXETF Comparison Chart in %
Loading...
BICX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EXETF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BICX vs. EXETF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BICX is a Hold and EXETF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (BICX: $0.36 vs. EXETF: $10.24)
Brand notoriety: BICX and EXETF are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BICX: 35% vs. EXETF: 46%
Market capitalization -- BICX: $18.29M vs. EXETF: $459.44M
BICX [@Medical/Nursing Services] is valued at $18.29M. EXETF’s [@Medical/Nursing Services] market capitalization is $459.44M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $88.21B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $4.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BICX’s FA Score shows that 0 FA rating(s) are green whileEXETF’s FA Score has 3 green FA rating(s).

  • BICX’s FA Score: 0 green, 5 red.
  • EXETF’s FA Score: 3 green, 2 red.
According to our system of comparison, EXETF is a better buy in the long-term than BICX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BICX’s TA Score shows that 4 TA indicator(s) are bullish while EXETF’s TA Score has 4 bullish TA indicator(s).

  • BICX’s TA Score: 4 bullish, 3 bearish.
  • EXETF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BICX is a better buy in the short-term than EXETF.

Price Growth

BICX (@Medical/Nursing Services) experienced а +5.88% price change this week, while EXETF (@Medical/Nursing Services) price change was +1.14% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.51%. For the same industry, the average monthly price growth was +0.08%, and the average quarterly price growth was +9.96%.

Reported Earning Dates

BICX is expected to report earnings on Aug 18, 2025.

EXETF is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Medical/Nursing Services (+1.51% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EXETF($459M) has a higher market cap than BICX($18.3M). EXETF YTD gains are higher at: 40.853 vs. BICX (-5.263). EXETF has higher annual earnings (EBITDA): 57.3M vs. BICX (-3.18M). EXETF has more cash in the bank: 105M vs. BICX (204K). BICX has less debt than EXETF: BICX (1.9M) vs EXETF (397M). EXETF has higher revenues than BICX: EXETF (1.24B) vs BICX (234K).
BICXEXETFBICX / EXETF
Capitalization18.3M459M4%
EBITDA-3.18M57.3M-6%
Gain YTD-5.26340.853-13%
P/E RatioN/A140.85-
Revenue234K1.24B0%
Total Cash204K105M0%
Total Debt1.9M397M0%
FUNDAMENTALS RATINGS
BICX vs EXETF: Fundamental Ratings
BICX
EXETF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
13
Undervalued
PROFIT vs RISK RATING
1..100
10017
SMR RATING
1..100
10017
PRICE GROWTH RATING
1..100
6142
P/E GROWTH RATING
1..100
6968
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EXETF's Valuation (13) in the null industry is significantly better than the same rating for BICX (98). This means that EXETF’s stock grew significantly faster than BICX’s over the last 12 months.

EXETF's Profit vs Risk Rating (17) in the null industry is significantly better than the same rating for BICX (100). This means that EXETF’s stock grew significantly faster than BICX’s over the last 12 months.

EXETF's SMR Rating (17) in the null industry is significantly better than the same rating for BICX (100). This means that EXETF’s stock grew significantly faster than BICX’s over the last 12 months.

EXETF's Price Growth Rating (42) in the null industry is in the same range as BICX (61). This means that EXETF’s stock grew similarly to BICX’s over the last 12 months.

EXETF's P/E Growth Rating (68) in the null industry is in the same range as BICX (69). This means that EXETF’s stock grew similarly to BICX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BICXEXETF
RSI
ODDS (%)
Bearish Trend 5 days ago
63%
Bullish Trend 5 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
55%
Momentum
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
49%
MACD
ODDS (%)
Bullish Trend 5 days ago
74%
N/A
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
65%
Bullish Trend 5 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
71%
Bearish Trend 5 days ago
54%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
59%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
61%
Aroon
ODDS (%)
N/A
Bullish Trend 5 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
BICX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EXETF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HASGX14.270.16
+1.13%
Harbor Small Cap Growth Instl
OCSGX6.830.07
+1.04%
Optimum Small-Mid Cap Growth C
WIMVX12.090.10
+0.83%
Segall Bryant & Hamill Glb All Cp Inst
GGESX24.900.18
+0.73%
Nationwide Global Sust Eq Instl Svc
JVACX39.210.18
+0.46%
JPMorgan Value Advantage C

BICX and

Correlation & Price change

A.I.dvisor tells us that BICX and AGL have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BICX and AGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BICX
1D Price
Change %
BICX100%
N/A
AGL - BICX
21%
Poorly correlated
+1.67%
BUGDF - BICX
5%
Poorly correlated
N/A
OPCH - BICX
4%
Poorly correlated
+0.42%
EXETF - BICX
3%
Poorly correlated
+0.49%
FSNUY - BICX
3%
Poorly correlated
-0.16%
More

EXETF and

Correlation & Price change

A.I.dvisor tells us that EXETF and FSNUF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXETF and FSNUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXETF
1D Price
Change %
EXETF100%
+0.49%
FSNUF - EXETF
28%
Poorly correlated
N/A
FSNUY - EXETF
25%
Poorly correlated
-0.16%
INNV - EXETF
25%
Poorly correlated
+7.47%
FMCQF - EXETF
7%
Poorly correlated
N/A
CCEL - EXETF
5%
Poorly correlated
-0.96%
More